Press Room Video Gallery CEO, Cameron Reynolds discusses with Andrew Scott positive interim results from Danish colorectal cancer study CEO, Cameron Reynolds discusses with Andrew Scott positive interim results from Danish colorectal cancer study Play video Video gallery 2020 Volition Corporate Film Play video 2019 Full Year Earnings Video with French Subtitles Play video 2019 Full Year Earnings Video with German Subtitles Play video Proactive Investors interview Cameron Reynolds, CEO Play video 2019 Full Year Results - an interview with Cameron Reynolds Play video Cameron Reynolds speaking about Volition's Assay Development Program Play video An interview with Cameron Reynolds - 2019 Highlights, Octamer Acquisition and Look Ahead to 2020 Play video Volition Announces Strategic Acquisition Play video VolitionRx and Gyros Protein Technologies Awarded an Aggregate $1 million+ Eurostars Cash Grant to Collaborate on Developing a Lung Cancer Blood Test Play video
